WeVote
Log In

Bill

Bill

SB 305

Relating to: grants to mental health clubhouses and making an appropriation. (FE)

2025-2026 Regular Session Introduced by Rachael Cabral-Guevara

Arkansas Act 491 mandates testing for processed medical marijuana products, ensuring safety and quality for consumers while holding producers to health standards.

Failed to pass pursuant to Senate Joint Resolution 1
0
WeVote Research Nonpartisan
Bill Summary · SB 305

Summary of Senate Bill 305 (SB 305)

Overview

Senate Bill 305, now known as Act 491, was introduced in the Arkansas General Assembly on February 25, 2025. The bill mandates specific testing requirements for processed marijuana products sold as medical marijuana in the state. The intent of the legislation is to ensure the safety and quality of these products for consumers.

Key Provisions

The bill amends Arkansas Code Title 20, Chapter 56, Subchapter 3, by adding a new section (20-56-309) that outlines the following provisions:

  1. Definition of Processed Marijuana Product:

    • The bill defines "processed marijuana product" as any marijuana product intended for human consumption that has undergone alteration from its original form. This includes products such as:
      • Edibles
      • Oils
      • Concentrations
      • Tinctures
      • Topicals
      • Inhalables
    • It clarifies that processed marijuana products are distinct from marijuana paraphernalia, which requires combustion for use.

  2. Testing Requirements:

    • All processed marijuana products must be tested after processing and before packaging.
    • Testing must comply with the rules set forth by the Arkansas Department of Health and includes checks for:
      • Pesticides
      • Heavy metals
      • Microbiological contaminants
      • Residual solvents
      • Concentrations of tetrahydrocannabinol (THC) and cannabidiol (CBD)

  3. Product Authorization:

    • The bill does not authorize or prohibit any specific marijuana products, including prerolls or blunts.

Impact

The enactment of SB 305 will primarily affect:
- Medical Marijuana Producers: They will be required to implement testing protocols for their processed products, ensuring compliance with health and safety standards.
- Consumers: Patients using medical marijuana will benefit from increased safety and assurance regarding the quality of the products they consume.
- Regulatory Bodies: The Arkansas Department of Health will oversee the implementation of testing standards and ensure compliance among producers.

Legislative Timeline

  • February 25, 2025: Bill filed and read for the first time.
  • March 12, 2025: Amendment #1 adopted, and the bill was reported correctly engrossed.
  • April 3, 2025: The bill passed the House and was ordered enrolled.
  • April 9, 2025: Notification that SB 305 is now Act 491.

Conclusion

SB 305 represents a significant step towards enhancing the safety and quality of medical marijuana products in Arkansas. By instituting mandatory testing, the legislation aims to protect consumers and promote public health within the state's medical marijuana program.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.